Closed Loop Medicine

We are excited to announce the appointment of Paul Johnson 🇬🇧🇺🇸 to the Board as an Independent Non-Executive Director. Bringing his unique and extensive experience in developing and scaling digital healthcare and e-commerce platforms, Paul joins at a pivotal stage in the company's development to support the leadership team in advancing the commercialization strategy for our portfolio of integrated precision care solutions. Welcome to our team, Paul! Read more: https://lnkd.in/eviR3G2c #PressRelease #Appointment #PrecisionCare 

📢 New announcement! We have been selected to join NVIDIA Inception, an accelerator program led by world-leading Artificial Intelligence Computing company, NVIDIA, designed to nurture startups and early-stage companies revolutionizing industries with technological advancements. Being able to work closely with NVIDIA’s team and the broader Inception program is a fantastic opportunity, providing the Closed Loop Medicine team with access to the latest tools, expertise, and leading industry and investor networks to accelerate our business growth. The program will support the development of our expanding portfolio of drug-plus-software combination products and entry into broader therapeutic areas. For the full announcement, visit our website: https://lnkd.in/dTarHTsQ #TechBio #NVIDIAInception

This week, our CEO Hakim Yadi Ph.D. OBE will be heading over to Orlando for the American Diabetes Association 84th Annual Scientific Session which begins Friday 21st June. If you're attending the event, reach out to discuss how Closed Loop Medicine is improving outcomes for patients with chronic diseases through its expanding portfolio of drug-plus-software combination products: https://shorturl.at/fMcea   #ADA2024 #TechBio #PrecisionCare

The American Diabetes Association returns for its 84th Annual Scientific Session on June 21st, bringing together researchers, healthcare professionals, and industry experts to delve into the latest advancements in diabetes research, treatment, and care.    With session themes focusing on therapeutics, management of acute or chronic complications, and behavioural medicine, it’s worth highlighting that the effectiveness of any treatment depends on its efficacy, safety, and patient adherence. Patient-centric integrated care approaches that enable real-time patient monitoring play a pivotal role in ensuring medication adherence and mitigating the risk and severity of complications associated with obesity, such as diabetes and hypertension.   Get in touch to arrange a meeting with Hakim Yadi Ph.D. OBE! Learn more about how Closed Loop Medicine is facilitating personalized disease management through our expanding portfolio of drug-plus-software combination products, to improve the effectiveness of medicines, such as GLP-1s, while reducing the impact of adverse effects:  https://shorturl.at/fMcea   #ADA2024 #TechBio #PrecisionCare

Day 2 of the BIO International Convention is in full swing. Irene Patzak,Mel Walker and I are making some great new connections as well as smashing our daily steps targets negotiating the huge conference centre!   Schedule a one-to-one #partnering meeting to learn more about how @Closed Loop Medicine has the potential to transform healthcare and improve patient outcomes through our integrated precision care solutions: https://rb.gy/4dpvcn   #BIO2024 #TechBio #PrecisionCare #DigitalHealth.

‘Silent but deadly: hypertension and how to treat it’   In this latest issue of European Biopharmaceutical Review (EBR), our CEO Hakim Yadi Ph.D. OBE, shares his insights on why mismanaged hypertension is such a risk to global healthcare, discusses the limitations facing the current treatment landscape and explores how novel technology applications enabling personalized dosing can revolutionize chronic disease management and precision care for the individual.    “The effectiveness of any treatment depends on its efficacy, safety, and patient adherence. Innovations in technology and data acquisition have driven the development of platforms aimed at enhancing patient monitoring, improving medications effectiveness and transforming chronic disease management.”   Find a link to full interview in the comments below.    #Hypertension #PrecisionCare #TechBio #Interview

In this Citeline episode of the In Vivo podcast, our CEO Hakim Yadi Ph.D. OBE spoke to David Wild about Closed Loop Medicine’s proprietary platform and how our approach in pairing software as a medical device with advanced analytics and drugs can enhance personalized care across multiple therapeutic areas.   💡 The vast majority of medicines have been trialed, developed, marketed and launched using a one-size-fits-all approach. As part of the discussion, Hakim shares his insights on how we can shift this paradigm to provide a precision care approach: “With the advent of digital health and software as a medical device, we now have the opportunity to capture high fidelity data on patients to understand an individual's therapeutic window and to use that information to enhance their therapy regimen, by selecting the right dose for them. That could mean the ability to maximize efficacy but minimize size side effects. Being able to identify the dose that is most tolerable to a patient, which means they're going to adhere and stay on that medication, becomes really important.”   “We hear stories of patients cutting, crushing and even nibbling a tablet… We're in the 21st century, we have the tools and technology to understand what is appropriate for an individual.”   Want to hear more about Closed Loop Medicine’s approach to treating the individual not just the disease, how industry partnerships aim to bring back value to existing medicines for hypertension, and the potential of applying precision care other therapeutic areas, including in the GLP-1 market? Listen to the full podcast linked in the comments below ⬇ #Podcast #Interview #PrecisionCare #TechBio

📢 We are hiring! We see a world where we treat the individual, not just the disease. Now is an exciting time to join our friendly and supportive team as we strive to enable precision medicine by combining dose-optimized drug therapy with digital care. 𝗦𝗼𝗳𝘁𝘄𝗮𝗿𝗲 𝗘𝗻𝗴𝗶𝗻𝗲𝗲𝗿 ➡ https://rb.gy/fp1fig We are looking for a Software Engineer to join our Software Delivery team, focused on building a novel technology platform as well as drug and digital products for personalized medicine. 𝗜𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗠𝗮𝗻𝗮𝗴𝗲𝗿 ➡ https://rb.gy/5w7ius We are looking for an IT Manager to oversee the running of our computer systems according to requirements, specifications, costs, and timelines. You will also supervise the implementation and maintenance of our computing and infrastructure needs. #London #Hiring #SoftwareEngineer #ITManager #PrecisionMedicine #DigitalCare

A year on from announcing our collaboration with Pharmanovia on #WorldHypertensionDay in 2023, now on the eve of World Hypertension Day ’24 we can announce the first patient recruitment to a proof-of-concept study investigating personalized dose management of an anti-hypertensive in improving blood pressure control. Thank you to everyone from Closed Loop Medicine and Pharmanovia and our #NHS collaborators for making this happen. #PrecisionCare For All #TreatingTheIndividualNotJustTheDisease

Tomorrow, on May 17th, is #WorldHypertensionDay – a day bringing global awareness to the 1 billion people living with high blood pressure worldwide, and a leading preventable cause of morbidity and premature death. Exactly one year after we announced our partnership with Pharmanovia, we are excited to announce the first patient recruitment to a proof-of-concept study investigating personalized dose management of an anti-hypertensive in improving blood pressure control. #PrecisionCare #TechBio #Hypertension #PressRelease   COR2024SM00107 Date Prepared: May 2024